Combination of vitiligo and Sutton`s nevus. A case report
- Autores: Nemchaninova О.В.1, Simonova E.P.2, Reshetnikova T.B.1, Melnichenko N.V.3, Pozdnyakova O.N.1
-
Afiliações:
- Novosibirsk State Medical University
- Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
- Dermatology Center NEO
- Edição: Volume 31, Nº 5 (2024)
- Páginas: 148-152
- Seção: Clinical case
- URL: https://journals.eco-vector.com/2073-4034/article/view/639879
- DOI: https://doi.org/10.18565/pharmateca.2024.5.148-152
- ID: 639879
Citar
Texto integral



Resumo
Background. Halo nevus (Sutton`s nevus) and vitiligo are multifactorial diseases with a hereditary predisposition and with the leading role of autoimmune mechanism of melanocyte destruction in their development. Each of these conditions as an independent pathology is a well-studied disease from the group of dyschromias, their clinical signs are described in detail, a sufficient amount of data on dermatoscopic and immunohistochemical pictures has been accumulated. The incidence of the combination of vitiligo and Sutton nevus (SN), according to the literature, varies from 18 to 26% of cases, since SN is not always considered as a separate nosology. The high frequency of association of these dyschromias is attributable to common cell-mediated autoimmune mechanisms of their development. Their long-term chronic progressive course significantly reduces the quality of life of patients, often leading to deep psychosocial experiences, especially when exposed areas of the skin (face, hands) are affected. When SN appears against the background of existing vitiligo, as well as when halo nevus-associated leukoderma appears, difficulties in making a diagnosis arise, which requires differential diagnostics based on clinical and dermatoscopic pictures of the disease to determine the tactics of patient management.
Description of the clinical case. The article presents author’s own clinical observation of the long-term existence of a combination of vitiligo and multiple SN in a 22-year-old patient. Multiple SN began to form sequentially around congenital nevi a year after the onset of vitiligo. Dermatoscopic examination revealed that the vitiligo foci were at different stages of development, while the SN had the same structure. The absence of spontaneous regression or partial repigmentation of SN over a long period of time is a reason for regular clinical and dermatoscopic monitoring of the patient.
Conclusion. The presented case raises physicians’ awareness of the possibility of combining vitiligo and SN and the nuances of differential diagnosis of these dyschromias based on clinical and dermatoscopic criteria.
Palavras-chave
Texto integral

Sobre autores
О. Nemchaninova
Novosibirsk State Medical University
Email: symonovaep@yandex.ru
ORCID ID: 0000-0002-5961-6980
Rússia, Novosibirsk
E. Simonova
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Autor responsável pela correspondência
Email: symonovaep@yandex.ru
ORCID ID: 0000-0003-2124-340X
Cand. Sci. (Med.), Junior Researcher
Rússia, NovosibirskT. Reshetnikova
Novosibirsk State Medical University
Email: symonovaep@yandex.ru
ORCID ID: 0000-0002-6156-0875
Rússia, Novosibirsk
N. Melnichenko
Dermatology Center NEO
Email: symonovaep@yandex.ru
Rússia, Novosibirsk
O. Pozdnyakova
Novosibirsk State Medical University
Email: symonovaep@yandex.ru
ORCID ID: 0000-0003-1389-1001
Rússia, Novosibirsk
Bibliografia
- Петунина В.В., Потекаев Н.Н., Жукова О.В. Тенденции в исследованиях витилиго в срезе изучения механизмов его развития и коморбидной аутоиммунной патологии. Клиническая дерматология и венерология. 2022;3:291–95. [Petunina V.V., Potekaev N.N., Zhukova O.V. Research trends in vitiligo development mechanisms and concomitant autoimmune conditions. Russian Journal of Clinical Dermatology and Venereology. 2022;21(3):291–95. (In Russ.)]. doi: 10.17116/klinderma202221031291.
- Красносельских Т.В., Аравийская Е.Р., Соколовский Е.В., Монахов К.Н. Справочник практического врача по наиболее часто встречающимся дерматозам. М., 2023. [Krasnoselsky T.V., Arawiyskaya E.R., Sokolovsky E.V., Monakhov K.N. Handbook of a practical doctor on the most common dermatoses. M., 2023. (In Russ.)].
- Edwards C. Measurement of vitiligo: human vs. Machine. Br J Dermatol. 2019;180(5):991. doi: org/10.1111/bjd.17506.
- Alkhateeb A., Fain P.R., Thody A., et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16(3):208–14. doi: 10.1034/j.1600-0749.2003.00032.x.
- Bergqvist C., Ezzedine K. Vitiligo: a review. Dermatology. 2020;236(6):57–92. doi: 10.1159/000506103.
- Kruger C., Schallreuter K.U. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206–12. doi: 10.1111/j.1365-4632.2011.05377.x.
- Picardo M., Dell’Anna M.L., Ezzedine K., et al. Vitiligo. Nat Rev Dis Primers. 2015;1:15011. doi: 10.1038/nrdp.2015.11. [PMID: 27189851].
- Mastacouris N., Strunk A., Garg A. Incidence and prevalence of diagnosed vitiligo according to race and ethnicity, age, and sex in the US. JAMA. Dermatology. 2023;159:986–90. doi: 10.1001/jamadermatol.2023.2162.
- Silverberg J.I., Reja M., Silverberg N.B. Regional variation of and association of US birthplace with vitiligo extent. JAMA. Dermatology. 2014;150(12):1298–305. doi: 10.1001/jamadermatol.2014.899.
- Ezzedine K., Lim H., Suzuki W.T., et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res.2012;25(3):E1–13. doi: 10.3390/antiox12010176.
- Di Bartolomeo L., Custurone P., Irrera N., et al. Vitiligo and Mental Health: Natural Compounds’ Usefulness. Antioxidants. 2023;12(1):176. doi: 10.3390/antiox12010176.
- Ezzedine K., Eleftheriadou V., Jones H., et al. Psychosocial effects of vitiligo: a systematic literature review. Am J Clin Dermatol. 2021;1–18. doi: 10.1007/s40257-021-00631-6.
- Thompson A.R., Eleftheriadou V., Nesnas J. The mental health associations of vitiligo: UK population-based cohort study. B J Psych Open. 2022;8(6):190. doi: 10.1192/bjo.2022.591.
- Vallerand I.A., Lewinson R.T., Parsons L.M., et al. Vitiligo and major depressive disorder: A bidirectional population-based cohort study. J Am Acad Dermatol. 2019;80(5):1371–79. doi: 10.1016/j.jaad.2018.11.047.
- Хэбиф Т.П. Кожные болезни: диагностика и лечение. Пер. с англ. Под общ. ред. А.А. Кубановой. М., 2007. [Hebif T.P. Skin Diseases: Diagnosis and Treatment. Translated from English. Ed. by A.A. Kubanova. M., 2007. (In Russ.)].
- Мордовцева В.В., Сергеев Ю.Ю. Гало-феномен: обзор литературы и редкие клинические случаи. Фарматека. 2018;51:52–6. [Mordovtseva V.V., Sergeev Yu.Yu. Halo phenomenon: literature review and rare clinical cases. Farmateka. 2018;51:52–6. (In Russ.)]. doi: 10.18565/pharmateca.2018.s1.52-6.
- Aouthmany M., Weinstein M., Zirwas M.J., et al. The natural history of halo nevi: a retrospective case series. J Am Acad Dermatol. 2012;67(4):582–86. doi: 10.1016/j.jaad.2011.11.937.
- De Schrijver S., Theate I., Vanhooteghem O. Halo nevi are not trivial: About 2 young patients of regressed primary melanoma that simulates halo nevi. Case Rep Dermatol Med. 2021;2021:6672528. doi: 10.1155/2021/6672528.
- Yang Y., Morriss S., Rodrigues M. Dermoscopy in vitiligo, diagnostic clues and markers of disease activity: a review of the literature. Clin Exp Dermatol. 2024:365. doi: 10.1093/ced/llad365.
- Rongioletti F., Cecchi F., Rebora A. Halo phenomenon in melanocytic nevi (Sutton’s nevi). Does the diameter matter? J Eur Acad Dermatol Venereol. 2011;25:1231–32. doi: 10.1111/j.1468-3083.2010.03790.x.
- Ramachandran V., Kim K.M., Zhang L. Disseminated Nonsegmental Vitiligo Associated With Halo Nevi and Premature Gray Hair. Cureus. 2021;13:e13868. doi: 10.7759/cureus.1386.
- Patrizi A., Bentivogli M., Raone B., et al. Association of halo nevus/i and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol. 2013;27:e148–52. doi: 10.1111/j.1468-3083.2012.04504.x.
Arquivos suplementares
